Beyond the needle: engineering and industrial insight on oral delivery devices for biologics
Journal of Controlled Release · 2026-11 · 399 · 115371
DOI: 10.1016/j.jconrel.2026.115371 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Mengxuan Ji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, …. Hauptthemen laut MEDLINE: Biological Products, Drug Delivery Systems. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
The development of biologics has transformed disease treatment, yet their clinical use remains constrained by a reliance on parenteral administration. Oral delivery offers a more patient-friendly alternative, but its effectiveness is limited by a range of physiological and biochemical barriers. Recent advances in ingestible robotic devices provide a promising pathway for oral delivery of biologics by enabling controlled release and site-specific targeting. Yet despite this momentum, no device-enabled oral biologic has reached regulatory approval. This review surveys current robotic oral delivery technologies, classifying them according to their power and actuation strategies, mechanisms of mucus interaction or penetration, and target regions of the gastrointestinal system. For each category, we examine underlying design principles, along with key advantages and limitations. We also present an industrial perspective on development status and commercial potential, highlighting translational challenges related to manufacturing, regulatory approval, and clinical integration. This review investigates the underappreciated downstream consequences of early-stage engineering decisions on manufacturing scalability, regulatory classification, chronic biocompatibility, and cost of goods. Here, we evaluate translational viability by defining the engineering, pharmacokinetic, safety, and economic criteria that devices must simultaneously satisfy to advance beyond proof-of-concept.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9NH, UK.
- Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK.
- Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9NH, UK; Department of Pharmacology and Pharmacy, Li Ka Shi…
- Dosage Form Design & Development, AstraZeneca, The Discovery Centre (DISC), Biomedical Campus, 1 Francis Crick Ave, Trumpington, Cambridge CB2 0AA, UK.
- Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9NH, UK. Electronic address: Alhnan@kcl.ac.uk.
Förderung
- China Scholarship Council
Zitieren
APA
Ji, M., Lu, Y., Arcovio, K., Wang, Y., Al-Jamal, K. T., Bolodeoku, J., Forte, A. E., Ke, P., Shanmugam, R. K., & Alhnan, M. A. (2026). Beyond the needle: engineering and industrial insight on oral delivery devices for biologics. Journal of Controlled Release, 399, 115371. https://doi.org/10.1016/j.jconrel.2026.115371
Vancouver
Ji M, Lu Y, Arcovio K, Wang Y, Al-Jamal KT, Bolodeoku J, et al. Beyond the needle: engineering and industrial insight on oral delivery devices for biologics. Journal of Controlled Release. 2026;399:115371. doi:10.1016/j.jconrel.2026.115371
BibTeX
@article{Ji2026,
author = {Ji, Mengxuan and Lu, Yulan and Arcovio, Kasandra and Wang, Yuxuan and Al-Jamal, Khuloud T and Bolodeoku, John and Forte, Antonio E and Ke, Peng and Shanmugam, Ramesh Kumar and Alhnan, Mohamed A},
title = {Beyond the needle: engineering and industrial insight on oral delivery devices for biologics},
journal = {Journal of Controlled Release},
year = {2026},
volume = {399},
pages = {115371},
doi = {10.1016/j.jconrel.2026.115371}
}
EUVIMED